GeneScience Pharmaceuticals Co., Ltd. (GenSci)
↗Changchun, China
GeneScience Pharmaceuticals (GenSci) is a leading, fully integrated biopharmaceutical company based in China, established in 1996. It is a major subsidiary of the publicly traded Changchun High-Tech Industries (Group) Co., Ltd. (SZSE: 000661).
GenSci specializes in the research, development, manufacturing, and commercialization of innovative therapies, with a strong commercial leadership in recombinant human growth hormone (rhGH) products, including Jintropin and Jintrolong. The company operates across multiple therapeutic areas, including endocrinology, metabolism, immunology, respiratory diseases, oncology, and women's and pediatric health.
CLASSIFICATION
SIZE & FINANCIALS
Employees:5001-10000
Founded:1996
Ownership:subsidiary
Status:operating
STOCK
Exchange:SZSE
Ticker:000661
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Biologics, Small molecule, Recombinant proteins
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Changchun High-Tech Industries (Group) Co., Ltd.
Acquired By:Changchun High-Tech Industries (Group) Co., Ltd. (2019-06-01)
Key Partnerships:Yarrow Bioscience (Global ex-China rights for GS-098/YB-101), Foresee Pharmaceuticals (Commercialization of Camcevi in China)
COMPETITION
Position:Leader
LINKS
Website:gensci-china.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of GeneScience Pharmaceuticals Co., Ltd. (GenSci) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with GeneScience Pharmaceuticals Co., Ltd. (GenSci). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.